Free tool
FAERS Monitor: Sarafem
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018936 or its brand name (Sarafem, Fluoxetine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
63,050
Serious
39,616
63% of reports
Hospitalization
17,341
Death reported
3,988
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,661
- fatigue4,344
- nausea4,301
- headache3,758
- depression3,706
- anxiety3,422
- pain3,103
- dizziness2,925
- diarrhoea2,863
- off label use2,734
- insomnia2,671
- dyspnoea2,641
- vomiting2,530
- fall2,447
- weight increased2,210
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,705 |
| 2005 | 1,710 |
| 2006 | 1,680 |
| 2007 | 1,443 |
| 2008 | 1,409 |
| 2009 | 1,920 |
| 2010 | 2,252 |
| 2011 | 2,519 |
| 2012 | 3,268 |
| 2013 | 2,581 |
| 2014 | 2,868 |
| 2015 | 5,363 |
| 2016 | 4,442 |
| 2017 | 3,305 |
| 2018 | 3,296 |
| 2019 | 3,332 |
| 2020 | 2,801 |
| 2021 | 2,462 |
| 2022 | 3,084 |
| 2023 | 2,963 |
| 2024 | 3,226 |
| 2025 | 3,036 |
| 2026 | 2,383 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,109 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| depressionSignal | 3,706 | 5.5 | 5.3 | 13,589 |
| anxietySignal | 3,422 | 4.0 | 3.9 | 7,862 |
| insomniaSignal | 2,671 | 3.4 | 3.2 | 4,459 |
| weight increasedSignal | 2,210 | 3.3 | 3.2 | 3,573 |
| fallSignal | 2,447 | 2.5 | 2.4 | 2,144 |
| headacheSignal | 3,758 | 2.0 | 1.9 | 1,940 |
| dizziness | 2,925 | 2.0 | 1.9 | 1,404 |
| fatigue | 4,344 | 1.9 | 1.8 | 1,802 |
| nausea | 4,301 | 1.8 | 1.8 | 1,633 |
| vomiting | 2,530 | 1.8 | 1.7 | 913 |
| pain | 3,103 | 1.7 | 1.6 | 892 |
| dyspnoea | 2,641 | 1.6 | 1.5 | 541 |
| diarrhoea | 2,863 | 1.5 | 1.4 | 460 |
| drug ineffective | 4,661 | 1.2 | 1.1 | 136 |
| off label use | 2,734 | 1.0 | 1.0 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.